Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - TOTAL CURRENT LIABILITIES
Total Current Liabilities VRDN - Viridian Therapeutics, Inc.
26.6 M
LAST VALUE
39.76%
2 YEAR CAGR
31.66%
5 YEAR CAGR
34.38%
10 YEAR CAGR